SCHEMBL6804643

SCHEMBL6804643

COc1cc(C(=O)O)c(-c2ccc(C)cc2)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
MYC P01106 1/20 0.50
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
ALDH1A1 P00352 6/20 0.49
KDM4E B2RXH2 4/20 0.49
NPC1 O15118 1/20 0.49
MAPK1 P28482 1/20 0.49
RAB9A P51151 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MCL1 Q07820 1/20 0.47
TUBB4A P04350 1/20 0.45
TUBB P07437 1/20 0.45
TUBA3C P0DPH7 1/20 0.45
TUBA1B P68363 1/20 0.45
TUBA4A P68366 1/20 0.45
TUBB4B P68371 1/20 0.45
TUBB3 Q13509 1/20 0.45
TUBB2A Q13885 1/20 0.45
TUBB8 Q3ZCM7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8427571 0.85 ALDH1A1 (0.57) SMN1; SMN2MYCLCKFYNALDH1A1
SCHEMBL30832923 0.84 MCL1 (0.58) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL10058709 0.83 SMN1; SMN2 (0.49) SMN1; SMN2MYCLCKFYNALDH1A1
SCHEMBL6808918 0.81 AKR1C3 (0.55) SMN1; SMN2LCKFYNALDH1A1KDM4E
SCHEMBL8759234 0.80 ALDH1A1 (0.53) SMN1; SMN2MYCALDH1A1KDM4ENPC1
SCHEMBL17251283 0.80 ACHE (0.56) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL6802081 0.79 MCL1 (0.53) SMN1; SMN2ALDH1A1KDM4EHSD17B10MCL1
SCHEMBL6492271 0.79 SMN1; SMN2 (0.84) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL8566031 0.79 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL25642614 0.78 PRKAB2 (0.49) SMN1; SMN2LCKFYNALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 SMN1; SMN2 1854/4885MYC 4037/4885LCK 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.